Syndax Pharmaceuticals, Inc. (SNDX) Holders breakdown
- Shares held by all insiders: Latest value (m).
- Shares held by institutions: Latest value (m).
- Float held by institutions: Latest value (m).
- Institutions holding shares: Latest value (m).
| Breakdown | Latest value |
|---|---|
| Shares held by all insiders | (m) |
| Shares held by institutions | (m) |
| Float held by institutions | (m) |
| Institutions holding shares | (m) |
History
| Date | Shares held by all insiders | Shares held by institutions | Float held by institutions | Institutions holding shares |
|---|---|---|---|---|
| (m) Historical records are unavailable. | ||||
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |